Epigenetics and transcriptomics to detect adverse drug effects in model systems of human development.
about
Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic DiseasesEpigenetic Research of Neurodegenerative Disorders Using Patient iPSC-Based ModelsState-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiologyDevelopmental neurotoxicity - challenges in the 21st century and in vitro opportunitiesMicroRNA profiling as tool for in vitro developmental neurotoxicity testing: the case of sodium valproateA transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitorsReference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use.International STakeholder NETwork (ISTNET): creating a developmental neurotoxicity (DNT) testing road map for regulatory purposesIn vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities.Functional AdoMet Isosteres Resistant to Classical AdoMet Degradation Pathways.Adverse outcome pathways: opportunities, limitations and open questionsFrom smoking guns to footprints: mining for critical events of toxicity pathways in transcriptome data.Investigation into experimental toxicological properties of plant protection products having a potential link to Parkinson's disease and childhood leukaemia†Whole genome microarray analysis of neural progenitor C17.2 cells during differentiation and validation of 30 neural mRNA biomarkers for estimation of developmental neurotoxicity.Workshop of Scandinavian Society for Cell Toxicology 25-27 September 2013 in Denmark.Amniotic fluid stem cell models: A tool for filling the gaps in knowledge for human genetic diseases
P2860
Q26750573-65748910-B91B-440D-A44F-E3AE39DDC57CQ26772307-1B268B40-7EE7-418E-BED4-010B77CEE116Q26852097-FB4FDDAF-4BE8-4A75-9162-335C17AFB5B1Q28388774-761794FF-63F0-42C7-B956-61AA200F496AQ28539371-8A71A9AA-7169-41D7-A16A-25111BA41C7BQ30662775-DF2F15C9-5E6A-4113-9154-E4145B6FAA79Q30835700-4E6D650F-F71A-480F-AA78-EC94F90A4A66Q35024730-CF9C36CA-1EF0-4A4F-8BB4-67621065FDD7Q38753758-9E9ADC55-1628-4B6D-9412-C33D91974F1AQ41112322-E3D3480C-E489-4677-9A3E-DA28E72E308DQ42307037-BA48A2DC-481B-43E0-BC6C-40366BEE9B21Q42641582-76B0E450-3132-449B-B8BC-DA88EF933F35Q47159009-63923447-AE33-47B3-8E0C-5C46E229F6B0Q47904486-CF522C18-696B-4D39-BD91-F968CDCE5893Q50561249-855A2BDF-9909-4FE1-B116-9E3324C8366BQ57153004-F029A064-48B2-44CA-A85B-6DD54D159B72
P2860
Epigenetics and transcriptomics to detect adverse drug effects in model systems of human development.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Epigenetics and transcriptomic ...... systems of human development.
@en
type
label
Epigenetics and transcriptomic ...... systems of human development.
@en
prefLabel
Epigenetics and transcriptomic ...... systems of human development.
@en
P2860
P356
P1476
Epigenetics and transcriptomic ...... l systems of human development
@en
P2093
Nina V Balmer
P2860
P356
10.1111/BCPT.12203
P50
P577
2014-03-03T00:00:00Z